BWIN vs MRSH: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: BWIN is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BWIN and MRSH share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BWIN and MRSH exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

The Baldwin Insurance Group, Inc. (formerly BRP Group) is an independent insurance brokerage and advisory firm headquartered in Tampa, Florida, and founded in 2011. It distributes personal and commercial insurance through three operating groups: Insurance Advisory Solutions (middle-market and larger commercial clients), Mainstreet Insurance Solutions (personal lines and Medicare), and Underwriting Capacity and Technology Solutions, which houses managing general agent (MGA) programs that let Baldwin design its own specialty products and capture more of each transaction's economics. Its advisors assess client risk and place coverage across a broad carrier network, blending traditional brokerage with technology-enabled product development.

Full BWIN guide

Marsh (ticker MRSH, formerly Marsh & McLennan Companies under MMC) is a global professional services firm built around two segments. Risk and Insurance Services houses Marsh, the world's largest insurance brokerage, and Guy Carpenter, a leading reinsurance broker. The Consulting segment houses Mercer, a large health, wealth, and career consultancy, and Oliver Wyman, a management consulting brand. Together these businesses employ roughly 90,000 people and generate the bulk of revenue from recurring commissions and advisory fees tied to commercial insurance placement, reinsurance, retirement, and workforce advisory work.

Full MRSH guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BWIN drivers: Organic growth across operating groups; Acquisitions and partnership integration.
• MRSH drivers: Insurance brokerage scale and pricing cycle; Diversified consulting through Mercer and Oliver Wyman.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Baldwin runs at a GAAP net loss while reporting positive adjusted earnings, so the gap between the two, driven by amortization, interest, and deal costs, is a meaningful risk if adjusted metrics do not eventually convert to reported profit. For MRSH, as an insurance broker, revenue is tied to the commercial insurance pricing cycle, and a prolonged soft market with falling premium rates would slow commission growth.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BWIN if you believe its drivers more; MRSH if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BWIN and MRSH guides.

BWIN. As of July 2026, BWIN trades around a $4 billion market cap with shares near the high-$20s, and its trailing GAAP P/E is negative because the company reports a net loss. Investors instead value it on adjusted earnings (adjusted diluted EPS was about $0.63 in the first quarter of 2026) and on revenue and EBITDA growth, so the multiple reflects a growth-and-margin story rather than current GAAP profitability.

MRSH. Marsh generated roughly $27 billion in trailing revenue with high-single-digit organic growth and expanding adjusted margins. It trades around a low-20s price to earnings multiple, a premium that reflects its recurring fee revenue and steady compounding rather than rapid growth. The next quarterly report is expected in late July 2026.

Headline figures (approximate, July 2026): BWIN shows revenue (2025) ~$1.5B, q1 2026 revenue ~$532M, q1 2026 organic growth ~2%, adjusted ebitda margin (q1 2026) ~26%; MRSH shows revenue (ttm) ~$27.5B, net income (ttm) ~$4.2B, diluted eps (ttm) ~$7.99, market cap ~$86B.

BWIN and MRSH are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BWIN and MRSH exposure against your real portfolio. It is not an investment adviser.